Fusogenic extracellular vesicle delivery technology
Undisclosed programs RD ocular conditions, immune modulation
Vesigen Therapeutics is a developing exosome-based therapies for the treatment of a variety of diseases. Exosomes are small vesicles that are released by cells and can deliver cargo to other cells. Vesigen’s exosome engineering platform allows the company to engineer exosomes to deliver specific therapeutic cargo, such as siRNA, mRNA, or proteins. Vesigen is developing exosome-based therapies for a variety of diseases, including cancer, neurodegenerative diseases, and inflammatory diseases. The company's lead product candidate, VSG-101, is an exosome-based therapy for the treatment of glioblastoma multiforme (GBM), a type of brain cancer.